GU Cancers 2020 | RADVAX: pembrolizumab plus radiotherapy

VJOncology is committed to improving our service to you

Hans Hammers

Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the RADVAX trial (NCT02303990), a stratified Phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with advanced and metastatic Cancers. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter